| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
8,109 |
6,666 |
$3.64M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
13,288 |
12,210 |
$945K |
| 92134 |
|
18,678 |
18,041 |
$123K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
211 |
188 |
$71K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
7,981 |
7,734 |
$59K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,726 |
2,718 |
$25K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,668 |
1,614 |
$14K |
| 92235 |
|
712 |
670 |
$11K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
845 |
841 |
$9K |
| 92250 |
|
1,258 |
1,219 |
$9K |
| J9035 |
Injection, bevacizumab, 10 mg |
183 |
131 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
147 |
147 |
$3K |
| J7999 |
Compounded drug, not otherwise classified |
12 |
12 |
$80.50 |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
14 |
14 |
$54.88 |